Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions

References

• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
   PubMed Web of Science ®Google Scholar
• Bley H, Fussnegger B, Bodmeier R. Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm 2010;390:165–173.
   PubMed Web of Science ®Google Scholar
• Wang X, de Armas HN, Blaton N, Michoel A, Van den Mooter G. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52. Int J Pharm 2007;345:95–100.
   PubMedGoogle Scholar
• Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1–10.
   PubMed Web of Science ®Google Scholar
• Sekiguchi K, Obi N, Ueda Y. Studies on absorption of eutectic mixture. Ii. Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem Pharm Bull 1964;12:134–144.
   PubMed Web of Science ®Google Scholar
• Levy G. Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. Am J Pharm Sci Support Public Health 1963;135:78–92.
   PubMedGoogle Scholar
• Kanig JL. Properties of fused mannitol in compressed tablets. J Pharm Sci 1964;53:188–192.
   PubMed Web of Science ®Google Scholar
• Janssens S, de Armas HN, D’Autry W, Van Schepdael A, Van den Mooter G. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends. Eur J Pharm Biopharm 2008;69:1114–1120.
   PubMed Web of Science ®Google Scholar
• Wang X, Michoel A, Van den Mooter G. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC. Int J Pharm 2004;272:181–187.
   PubMedGoogle Scholar
• Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 2008;70:493–499.
   PubMed Web of Science ®Google Scholar
• Marín MT, Margarit MV, Salcedo GE. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. Farmaco 2002;57:723–727.
   PubMedGoogle Scholar
• Castro SG, Sanchez Bruni S, Lanusse CE, Allemandi DA, Palma SD. Improved Albendazole Dissolution Rate in Pluronic 188 Solid Dispersions. AAPS Pharm Sci Tech. Doi: 10.1208/s12249-010–9517-6. 2010
   Google Scholar
• Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R. Studies on mechanism of enhanced dissolution of albendazole solid dispersions with crystalline Carriers. Indian Journal of Pharmaceutical Sciences 2006; 68:599–607.
   Google Scholar
• Collett JH. Poloxamer. In: Rowe RC, Sheskey PJ, Quinn ME editors. Handbook of pharmaceutical excipients ed. 6th edition, London, Chicago:Pharmaceutical Press 2009; 506–509.
   Google Scholar
• Zhai H, Li S, Andrews G, Jones D, Bella S, Walker G. Nucleation and growth in fluidised hot melt granulation. Powder Technol 2009;189:230–237.
   Web of Science ®Google Scholar
• Vilhelmsen T, Eliasen H, Schaefer T. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int J Pharm 2005;303:132–142.
   PubMed Web of Science ®Google Scholar
• Wallik D. Polyethylene Glycol, In: Rowe RC, Sheskey PJ, Quinn ME editors. Handbook of pharmaceutical excipients. ed. 6th edition, London, Chicago:Pharmaceutical Press 2009; 517–522.
   Google Scholar
• Fawaz F, Bonini F, Guyot M, Bildet J, Maury M, Lagueny AM. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits. International Journal of Pharmaceutics 1996; 132:271–275.
   Google Scholar
• Damian F, Blaton N, Kinget R, Van den Mooter G. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int J Pharm 2002;244:87–98.
   PubMed Web of Science ®Google Scholar
• Wang X, Michoel A, Van den Mooter G. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC. International Journal of Pharmaceutics. 2004; 272:181–187.
   PubMedGoogle Scholar
• Cook GC. Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy. Parasitol Today (Regul Ed) 1990;6:133–136.
   PubMedGoogle Scholar
• Townsend LB, Wise DS. The synthesis and chemistry of certain anthelmintic benzimidazoles. Parasitol Today (Regul Ed) 1990;6:107–112.
   PubMedGoogle Scholar
• Sanchez Bruni SF, Jones DG, McKellar QA. Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals. J Vet Pharmacol Ther 2006;29:443–457.
   PubMedGoogle Scholar
• Jung H, Medina L, García L, Fuentes I, Moreno-Esparza R. Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide. J Pharm Pharmacol 1998;50:43–48.
   PubMed Web of Science ®Google Scholar
• Daniel-Mwambete K, Torrado S, Cuesta-Bandera C, Ponce-Gordo F, Torrado JJ. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm 2004;272:29–36.
   PubMed Web of Science ®Google Scholar
• Vogt M, Kunath K, Dressman JB. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur J Pharm Biopharm 2008;68:330–337.
   PubMed Web of Science ®Google Scholar
• Notari RE.Pharmacokinetics. Biopharmaceutics and Clinical Pharmacokinetics, In: Notari RE, editor, 4th edition, New York, NY, USA: Marcel Dekker Inc, 1987; 45–128.
   Google Scholar
• Gibaldi M, Perrier D. Pharmacokinetics. In: editor New York, USA:Marcel, Dekker. 2nd edition. 1982;45–109.
   Google Scholar
• Sánchez S, Sallovitz J, Savio E, Mckellar Q, Lanusse C. Comparative availability of two oral dosage forms of albendazole in dogs. Vet J 2000;160:153–156.
   PubMed Web of Science ®Google Scholar
• Jung H, Medina L, García L, Fuentes I, Moreno-Esparza R. Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide. J Pharm Pharmacol. 1998; 50:43–48.
   PubMed Web of Science ®Google Scholar
• Evrard B, Chiap P, DeTullio P, Ghalmi F, Piel G, Van Hees T et al. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. J Control Release 2002;85:45–50.
   PubMed Web of Science ®Google Scholar